BECTON DICKINSON AND CO (BDX) Stock News
NYSE:BDX - New York Stock Exchange, Inc. - US0758871091 - Common Stock
BDX Latest News and Analysis
BD to Announce Financial Results for its First Quarter of Fiscal 2025
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an...
BDX September 19th Options Begin Trading
Morgan Stanley Promotes Mahdavi, Teasdale to Run Americas M&A
Morgan Stanley has promoted Lily Mahdavi and Ben Teasdale to co-lead its mergers and acquisitions team in the Americas, according to a person familiar with the situation.
BD Boosts U.S. Manufacturing of Critical Medical Devices
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional investments in its U.S....
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the BD Onclarity™ HPV Assay...
BD Names Pamela Spikner as Chief Accounting Officer and Controller
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela Spikner has been named...
New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey,...
BD To Host Virtual 2025 Annual Meeting of Shareholders
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2025...
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health...
Becton Dickinson to Pay $175 Million to Settle SEC Probe
Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important products.
BD Resolves Previously Disclosed SEC Investigation
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has...
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
/PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in...
BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th...
YieldBoost Becton, Dickinson To 11% Using Options
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic...
BD Board Increases Dividend for 53rd Consecutive Year
/PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an...
BD Launches Enhanced Intraosseous System, Enabling Vascular Access in Seconds for Critical Care Situations
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular...
BD Named Among the 100 Best Corporate Citizens of 2024
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the...
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first...
BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial...
Becton Dickinson Hernia-Mesh Settlements Will Exceed $1 Billion
Becton Dickinson & Co. will pay more than $1 billion to resolve more than 38,000 lawsuits alleging medical patients suffered damaged organs from surgical mesh improperly used to treat hernias, according to people familiar with the deal who weren’t authorized to speak publicly.
Becton Dickinson Settles Vast Majority of Hernia-Mesh Lawsuits
Becton Dickinson & Co. has agreed to settle the vast majority of the thousands of lawsuits claiming hernia patients were harmed by improper surgical mesh made by units of the medical technology giant, ending one of the largest current mass-tort litigations in the US.